【researchmap】
https://researchmap.jp/read0064218

Miyazaki M, Makowka L, Falk R.E. Falk W, Venturi D, Ambus U, Falkj A.
Hyperthermo-chemotherapeutic in vivo isolated perfusion of the rat liver.
Cancer 1983; 51:1254-1260
Miyazaki M, Makowka L, Falk R.E, Falk J.A, Falk W, Venturi D.
Reversal of lethal, chemotherapeutically induced acute hepatic necrosis in rats by regenerating liver cytosol.
Surgery 1983; 94:142-150
Miyazaki M, Shimoda T, Itoh H, Kaiho T, Iimura K, koyama T, Nakagawa K, Andoh K, Ambiru S, Otawa S, Ogata A, Yasuda N, Hayashi S, Nakajima N.
Enhancement of cytotozicity of doxorubicin by varapamil in the hepatic artery infusion for liver tumors in rats.
Cancer 1993; 72:349-354
Miyazaki M, Itoh H, Kaiho T, Ambiru S, Togawa A, Sasada K, Shiobara M, Shimizu Y, Yosioka S, Yoshidome H, Nakjima N.
Portal vein recostruction at the hepatic hilus using a left renal vein graft.
J Am Coll Surg 1995; 180:497-498
Miyazaki M, Itoh H, Ambiru S, Shimizu H, Togawa A, Gohchi E, Nakajima N, Suwa T.
Radical surgery for advanced gallbladder carcinoma.
Br J Surg 1996; 83:478-481
Miyazaki M, Ito H, Nakhgawa K, Ambiru S, Shimizu H, Shimizu Y, Kato A, Nakamura S, Omoto H, Nakajima N, Kimura F, Suwa Y.
Aggressive surgical approaches to hilar cholangiocarcinoma.Hepatic or local resection?
Surgery 1998; 123:131-136
Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Shimizu Y, Okuno A, Nozawa S, Nukui Y, Yoshitomi H, Nakajima N.
Segments I and IV resection as a new approach for hepatic hilar cholangiocarcinoma.
Am J Surg 1998; 175:229-231
Yoshioka S, Miyazaki M, Shimizu H, Ito H, Nakagawa K, Ambiru S, Nakajima N, Fukuda Y.
Hepatis venous hemoglobin oxygen saturation predicts regenerative status of remnant liver after partial hepatectomy in rats.
Hepatology 1998; 27:1349-1353
Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Okuno A, Nukui Y, Yoshitomi H, Kusashio K, Furuya S, Nakajima N.
Aggressive surgical resection for hepatic metastases involving the inferior vena cava.
Am J Surg 1999; 177:294-298
Yoshidome H, Kato A, Miyazaki M, Edwatds MJ, Lemtsch AB.
IL-13 activates STAT6 and inhibits liver inkury induced by ischemia/reperfusion.
Am J Pathol 1999; 155:1059-1064
Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Okaya T, Shinmura K, Nakajima N.
Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocaocinoma.
J Am Coll Surg 1999; 189:575-583
Kataoka M, Shimizu H, Mitsuhashi N, Ohtsuka M, Wakabayashi Y, Ito H, Kimura F, Nakagawa K, Yoshidome H, Shimizu Y, Miyazaki M.
Effect of cold-ischemia time on C-X-C chemokine expression and neutrophil accumulation in the graft liver after orthotopic liver transplantation in rats.
Transplant 2002; 73:1730-1735
Takeuchi D, Yoshidome H, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Morita Y, Miyazaki M.
Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice.
Hepatology 2004; 39:699-710
Suzuki T, Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Sawada S, Miyazaki M.
Renal function is well maintained after use of left renal vein graft for vascular reconstruction in hepatobiliary-pancreatic surgery.
J Am Coll Surg 2006; 202:87-92
Miyazaki M, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Nozawa S.
Combined vascular resection in operative resection for hilar Cholangiocarcinoma:Does it work or not?
Surgery 2007; 141:581-588
Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Mituhashi N,Takeuchi D, Suda K, Takano S.
Extensive hilar bile duct resection using a transhepatic approach for patients with hepatic hilar bile duct diseases.
Am J Surg 2008; 196:125-129
Shimizu H, Sawada S, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Miyazaki M.
Clinical Significance of Biliary Vascular Anatomy of the Right Liver for Hilar Cholangiocarcinoma Applied to Left Hemihepatectomy.
Ann Surg. 2009; 249:435-439
Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Miyazaki M.
Aggressive Surgical Resection for Hilar Cholangiocarcinoma of the Left-side Predominance.
Ann Surg 2010; 251:281-286
Hosokawa I, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M.
Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy.
Ann Surg 2014; 259:1178-1185
Miyazaki M, Yoshitomi H, Shimizu H, Ohtsuka M, Yoshidome H, Furukawa K, Takayasiki T, Kuboki S, Okamura D, Suzuki D, Nakajima M.
Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile?
Surgery 2014; 155:58-66
Weber SM, Ribero D, O'Reilly EM, Kokudo N, Miyazaki M, Pawlik TM.
Intrahepatic cholangiocarcinoma: expert consensus statement.
HPB (Oxford) 2015; 17:669-680
Watanabe Y, Kuboki S, Shimizu H, Ohtsuka M, Yoshitomi H, Furukawa K, Miyazaki M.
A New Proposal of Criteria For the Future Remnant Liver Volume in Older Patients Undergoing Major Hepatectomy For Biliary Tract Cancer.
Ann Surg 2016. [Epub ahead of print]
Miyazaki M, Yoshitomi H, Takano S, Shimizu H, Kato A, Yoshidome H, Furukawa K, Takayashiki T, Kuboki S, Suzuki D, Sakai N, Ohtuka M
Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer.
Langenbecks Arch Surg 2017; 402:447-456
Miyazaki M, Shimizu H, Ohtuka M, Kato A, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, Takano S, Suzuki D, Higashihara T.
Portal vein thrombosis after reconstruction in 270 consecutive patients with portal vein resections in hepatopancreatobiliary (HPB) surgery.
Am J Surg. 2017 ;214(1):74-79
Miyazaki M, Shimizu H, Yoshitomi H, Kato A, Furukawa K, Takayashiki T, Kuboki S, Takano S, Ohtsuka M.
Clinical implication of surgical resection for recurrent biliary tract cancer: Does it work or not?
Ann Gastroenterol Surg. 2017;1:164-170